PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil

Introduction: The high metabolic rate and the short biological half-life of 5-flourouracil (5-FU) required a continuous administration of large doses and consequently resulting in high profile of adverse effects. Incorporation of 5-FU into biodegradable nanoparticles (NPs) would enhance the therapeu...

Full description

Bibliographic Details
Main Authors: Ashour, Abdelkader Elbadawy Abbas, Badran, Mohammad, Kumar, Ashok, Hussain, Tajamul, Alsarra, Ibrahim, Yassin, Alaa Eldeen
Format: Conference or Workshop Item
Language:English
English
English
Published: 2017
Subjects:
Online Access:http://irep.iium.edu.my/69493/
http://irep.iium.edu.my/69493/
http://irep.iium.edu.my/69493/1/Certificate%20of%20participation%20and%20poster%20in%20Controlled%20Release%20Society%20%28CRS%29%20Annual%20meeting%2C%20Boston%2C%20Ma%2C%20July%2016-19%2C%202017.pdf
http://irep.iium.edu.my/69493/7/2017CRSprogramBook_FINAL2.pdf
http://irep.iium.edu.my/69493/8/2017%20Controlled%20Release%20Society%20Annual%20Meeting%20Author%E2%80%99s%20name%2C%20title%20of%20presentation%20and%20university%20affiliation%20for%20poster%20p-450.pdf
id iium-69493
recordtype eprints
spelling iium-694932019-01-11T04:06:27Z http://irep.iium.edu.my/69493/ PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil Ashour, Abdelkader Elbadawy Abbas Badran, Mohammad Kumar, Ashok Hussain, Tajamul Alsarra, Ibrahim Yassin, Alaa Eldeen RM300 Drugs and their action Introduction: The high metabolic rate and the short biological half-life of 5-flourouracil (5-FU) required a continuous administration of large doses and consequently resulting in high profile of adverse effects. Incorporation of 5-FU into biodegradable nanoparticles (NPs) would enhance the therapeutic efficacy through prolongation of the biological half-life and the duration of tumour exposure to 5-FU. This study aimed to monitor the effect of physical incorporation of PEG on the attributes of 5-FU-loaded polymeric NPs. Methods: An emulsification-solvent evaporation technique was employed for the preparation of 5-FU-loaded NPs using polylactic-co-glycolic acid (PLGA) and polycaprolactone (PCL). The effect of incorporating polyethylene glycol (PEG6000) was also investigated. The prepared NPs were evaluated for their particle sizes and morphology and characterized by FTIR and X-ray diffraction. The in vitro drug release profiles were evaluated and the anticancer activity was assessed utilizing MTT assay Daoy, HepG2, and HT29 cancer-cell-lines. Results: The NPs average sizes were between 176±6.7-253.9±8.6 nm and zeta potential between -7.13± 0.13 and -27.06±3.18 mV. The 5-FU %EE of ranged between 31.96-73.54% and enhanced significantly by PEG incorporation. The SEM images showed spherical particles with smooth surfaces. The in vitro release studies showed an initial rapid 5-FU release up to 8 h followed by a slow release ranging from 36 to 84% after 72 h. The higher was the ratio of PEG, the faster was the drug release rate. Significant % cell death was achieved with all the prepared NPs in the three tested cancer cell lines after 48 and 72 hours incubations. The PEG ratio correlated well with the magnitude of cell death in both Doay and HepG cells only. Conclusion: The physical PEGylation resulted in significant increase in the entrapment and loading efficiency of 5-FU in both PLGA and PCL NPs. They also improved both the drug release profile and the extent of in vitro cytotoxicity in both Doay and HepG2 cancer cell lines. 2017-07-19 Conference or Workshop Item PeerReviewed application/pdf en http://irep.iium.edu.my/69493/1/Certificate%20of%20participation%20and%20poster%20in%20Controlled%20Release%20Society%20%28CRS%29%20Annual%20meeting%2C%20Boston%2C%20Ma%2C%20July%2016-19%2C%202017.pdf application/pdf en http://irep.iium.edu.my/69493/7/2017CRSprogramBook_FINAL2.pdf application/pdf en http://irep.iium.edu.my/69493/8/2017%20Controlled%20Release%20Society%20Annual%20Meeting%20Author%E2%80%99s%20name%2C%20title%20of%20presentation%20and%20university%20affiliation%20for%20poster%20p-450.pdf Ashour, Abdelkader Elbadawy Abbas and Badran, Mohammad and Kumar, Ashok and Hussain, Tajamul and Alsarra, Ibrahim and Yassin, Alaa Eldeen (2017) PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil. In: Controlled Release Society Annual Meeting & Exposition, 16-19 July 2017, Sheraton Boston Hotel, Boston, Massachusetts, USA. (Unpublished) https://crs.confex.com/crs/2017/meetingapp.cgi/Person/10723
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
English
topic RM300 Drugs and their action
spellingShingle RM300 Drugs and their action
Ashour, Abdelkader Elbadawy Abbas
Badran, Mohammad
Kumar, Ashok
Hussain, Tajamul
Alsarra, Ibrahim
Yassin, Alaa Eldeen
PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
description Introduction: The high metabolic rate and the short biological half-life of 5-flourouracil (5-FU) required a continuous administration of large doses and consequently resulting in high profile of adverse effects. Incorporation of 5-FU into biodegradable nanoparticles (NPs) would enhance the therapeutic efficacy through prolongation of the biological half-life and the duration of tumour exposure to 5-FU. This study aimed to monitor the effect of physical incorporation of PEG on the attributes of 5-FU-loaded polymeric NPs. Methods: An emulsification-solvent evaporation technique was employed for the preparation of 5-FU-loaded NPs using polylactic-co-glycolic acid (PLGA) and polycaprolactone (PCL). The effect of incorporating polyethylene glycol (PEG6000) was also investigated. The prepared NPs were evaluated for their particle sizes and morphology and characterized by FTIR and X-ray diffraction. The in vitro drug release profiles were evaluated and the anticancer activity was assessed utilizing MTT assay Daoy, HepG2, and HT29 cancer-cell-lines. Results: The NPs average sizes were between 176±6.7-253.9±8.6 nm and zeta potential between -7.13± 0.13 and -27.06±3.18 mV. The 5-FU %EE of ranged between 31.96-73.54% and enhanced significantly by PEG incorporation. The SEM images showed spherical particles with smooth surfaces. The in vitro release studies showed an initial rapid 5-FU release up to 8 h followed by a slow release ranging from 36 to 84% after 72 h. The higher was the ratio of PEG, the faster was the drug release rate. Significant % cell death was achieved with all the prepared NPs in the three tested cancer cell lines after 48 and 72 hours incubations. The PEG ratio correlated well with the magnitude of cell death in both Doay and HepG cells only. Conclusion: The physical PEGylation resulted in significant increase in the entrapment and loading efficiency of 5-FU in both PLGA and PCL NPs. They also improved both the drug release profile and the extent of in vitro cytotoxicity in both Doay and HepG2 cancer cell lines.
format Conference or Workshop Item
author Ashour, Abdelkader Elbadawy Abbas
Badran, Mohammad
Kumar, Ashok
Hussain, Tajamul
Alsarra, Ibrahim
Yassin, Alaa Eldeen
author_facet Ashour, Abdelkader Elbadawy Abbas
Badran, Mohammad
Kumar, Ashok
Hussain, Tajamul
Alsarra, Ibrahim
Yassin, Alaa Eldeen
author_sort Ashour, Abdelkader Elbadawy Abbas
title PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
title_short PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
title_full PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
title_fullStr PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
title_full_unstemmed PEGylation of PLGA and PCL nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
title_sort pegylation of plga and pcl nanoparticles enhanced the cytotoxicity of loaded 5-flurouracil
publishDate 2017
url http://irep.iium.edu.my/69493/
http://irep.iium.edu.my/69493/
http://irep.iium.edu.my/69493/1/Certificate%20of%20participation%20and%20poster%20in%20Controlled%20Release%20Society%20%28CRS%29%20Annual%20meeting%2C%20Boston%2C%20Ma%2C%20July%2016-19%2C%202017.pdf
http://irep.iium.edu.my/69493/7/2017CRSprogramBook_FINAL2.pdf
http://irep.iium.edu.my/69493/8/2017%20Controlled%20Release%20Society%20Annual%20Meeting%20Author%E2%80%99s%20name%2C%20title%20of%20presentation%20and%20university%20affiliation%20for%20poster%20p-450.pdf
first_indexed 2023-09-18T21:38:39Z
last_indexed 2023-09-18T21:38:39Z
_version_ 1777412991002607616